Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.0289 per EA under NDC 00591086001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 1, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5; 10 mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591086001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA076194FDA Approved
7/1/2002
TE Code
AB
On Market Since
7/1/2002
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0289 per EA |
|---|---|
| All-time high | $0.0407 (Aug 11, 2021) |
| All-time low | $0.0241 (Nov 20, 2024) |
| 52-week high | $0.0307 |
| 52-week low | $0.0284 |
| Median price | $0.0324 |
| Average price | $0.0330 |
| Largest weekly change | +41.0% (May 22, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Actavis Pharma, Inc., is $0.0289 per EA (NDC 00591086001), effective Aug 19, 2026.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 19.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.0241 (Nov 20, 2024) to a high of $0.0407 (Aug 11, 2021), with a median of $0.0324 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 00591086001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.